Abstract Aim of the work: This study aimed to investigate serum levels of vascular endothelial growth factor (VEGF) and to measure common carotid intima media thickness (cc-IMT) in Egyptian patients with Behc¸et's disease (BD) to evaluate their relations to disease activity and different clinical manifestations.
Results: The mean cc-IMT showed a significant difference in BD patients compared to controls (p < 0.011). Three BD patients had plaques (4.3%). There were significant correlations of cc-IMT with disease duration (p < 0.001), systolic blood pressure (BP) (p = 0.029), diastolic BP (p = 0.041), total cholesterol (p < 0.001) and LDL (p < 0.001) and insignificant correlation with BDCAF (p = 0.054). There was a significant elevation of VEGF levels (p < 0.001) in BD patients compared to controls. VEGF levels showed significant correlations with ESR (p = 0.14), CRP (p < 0.001) and BDCAF (P = 0.02), while there was an insignificant correlation with cc-IMT (p = 0.107).
Conclusion: BD patients have ultrasonographic evidence of subclinical atherosclerosis which was associated with increasing age, longer disease duration, elevated systolic and diastolic BP, total cholesterol and LDL. Elevated VEGF showed statistically significant positive correlations with BDCAF and thus can be used as a marker of disease activity and/or therapeutic targets in BD patients.
Introduction
Behc¸et's disease is a systemic vasculitis of unknown origin, characterized by recurrent oral and genital ulcers, uveitis, vascular manifestations and other multisystem affections [1, 2] . Vasculitis causes endothelial destruction and thrombosis [3] . Inflammatory thrombosis is well-known in BD [4] . It has been recognized that vascular endothelial dysfunction occurs in BD and plays a substantial role in the vascular lesions. The pathogenic mechanism is uncertain [5] .
There are several identified vascular endothelial growth factor (VEGF) family members: VEGF (VEGF-A), VEGF-B, VEGF-C, VEGF-D and placenta growth factor which are key regulators of physiological and pathological vasculogenesis, angiogenesis, lymphangiogenesis, hematopoiesis and vascular permeability. VEGF is essential for angiogenesis and inflammation that are pathophysiologic factors of BD [6] . Vascular endothelial growth factor (VEGF) is a potent cytokine that modulates angiogenesis and vasculogenesis by acting as an essential mitogen for vascular endothelial cells [7] . It is an important factor in the progression of atherosclerosis [8] .
Common carotid intima-media thickness is an endothelial cell dysfunction parameter that may be associated with atherosclerosis [9] . Its thickness is a known good predictor of cardiovascular accidents in the general population [10] and has been reported in the patients with different rheumatic diseases as a strong predictor of cardiovascular events [11] . The carotid artery can be studied by B-mode Doppler ultrasound which shows the carotid artery intima and media width that can be visualized in all subjects [12] .
Primary and secondary prevention of life-threatening thrombocoagulopathy in BD is a complex process. Aneurysmatic, pseudoaneurysmatic and thrombotic affections of large-and medium-size arteries and right-sided intracardiac thrombotic masses have been reported [13] . Atherosclerosis may develop during the course of BD [9] . Increased atherosclerotic changes may cause increased carotid IMT in BD [14] .
The aim of this study was to investigate serum levels of VEGF and to measure the cc-IMT in Egyptian patients with BD to evaluate their relations to disease activity and different clinical manifestations.
Patients and methods

Subjects
Seventy patients diagnosed as BD according to the International Study Group criteria (ISGC, 1990) [15] and 70 age and sex matched healthy volunteers serving as control group were enrolled into this study. This study was carried out between July 2010 and June 2011 and the patients were recruited and selected from inpatient and outpatient clinics of Rheumatology, Rehabilitation & Physical Medicine, General Medicine, Ophthalmology and Dermatology & Andrology of Benha University hospitals.
Exclusion criteria: patients were excluded from the study if they had other illnesses that might affect the results of the study (or are risk factor for atherosclerosis) such as diabetes mellitus or hypertension, hyperlipidemia, alcoholics, smokers, family history of atherosclerosis, manifest cardiac diseases (infarction, stent or coronary bypass), cerebrovascular events or the statin therapy as well as patients with other rheumatological diseases.
The local Ethics Committee of our institute approved the study and informed written consents were obtained from all participants.
Clinical assessments
All BD patients were subjected to the following: -Detailed history taking.
-Thorough clinical examination with stress on dermatological, locomotor, vascular and ophthalmologic examination and skin pathergy test [16] . -Assessment of disease activity according to Behc¸et's Disease Current Activity Form (BDCAF) score [17] . -All manifestations at the time of study or during the month before the study were considered. Concentrations were expressed in pg/ml after optical density determination at 450 nm. The detection limit of the VEGF assay was 9.0 pg/ml.
Biochemical assessments
Radiological examination
-High-resolution B-mode Doppler ultrasound examination: patients and controls underwent extracranial carotid arteries assessment by high resolution B-mode ultrasound in the Radiodiagnosis Department, Benha University Hospitals. The ultrasonographic scan protocol was performed on the last two centimeters of both common carotid arteries, prior to its bifurcation, by using TOSHIBA 526 -DEVICE equipped with 10 MHz imaging transducer to measure intima-media thickness in the common carotid artery (cc-IMT) in mm and detect the presence of atheromatous plaques. The measurement was repeated three times on each side (right and left) and the mean of the six measurements was used for this study. Plaques were defined as a distinct area protruding into the vessel lumen with at least 50% greater thickness than the surrounding areas. Statistical analysis: The program used was SPSS version 16. Quantitative data were analyzed using mean and standard deviation while frequency and percentage were used with qualitative data. Student's t test was used to compare means of different groups while chi square (x 2 ) to compare frequencies. Pearson correlation was used to find relationships between variables (r). A p value of <0.05 was considered to be significant.
Results
This study included 70 patients: 43 males (61.4%) and 27 females (38.6%). Their ages ranged from 22-46 years with a mean of 32.84 ± 3.63 years. Age and sex matched 70 healthy volunteers, as a control group [41 males (58.6%) and 29 females (41.4%)], aged from 21-48 years with a mean of 32.81 ± 3.89 years were also included. Patients' disease duration ranged from 2 to 12 years with a mean of 6.74 ± 2.16 years. There were 12 patients (17.1%) with vascular lesions: 10 had deep-vein thrombosis, one with pulmonary embolism and one had retinopathy. The mean BDCAF scores were 4.7 ± 4.2.
One patient (1.4%) was on steroid use of 20 mg/d for the last one month. Thirty-one (44.3%) patients were on the colchicine therapy (ranging between 1 and 1.5 mg/d), 11 (15.7%) were also on NSAIDs together with colchicine and two (2.9%) of them were taking low-dose steroids along with colchicine. Twenty-seven (38.6%) patients were on NSAIDs only. None of the patients were on the statin therapy.
Clinical manifestations, descriptive and laboratory data of BD patients and the control group are shown in (Tables 1  and 2 ). Serum levels of VEGF were significantly higher (t = 21.94, p < 0.001) in BD patients in comparison to the control group.
A statistically significant elevation of VEGF serum levels was observed in BD patients with skin lesions (t = 6.25, p < 0.001), arthritis (t = 7.42, p < 0.001), ocular lesions (t = 8.52, p < 0.001) and vascular lesions (t = 9.3, p < 0.001), while there was an insignificant increase of serum VEGF levels in patients with oral ulcers (t = 0.58, p = 0.56), genital ulcers (t = 0.98, p = 0.33) or a positive skin Pathergy test (t = 1.63, P = 0.107) ( Table 3 ).
In the ultrasound study of the common carotid artery, the mean cc-IMT in BD patients and controls was 0.67 ± 0.25 and 0.57 ± 0.15 mm, respectively with a statistically significant difference (p < 0.011) between both groups. Three BD patients (4.3%) had plaques while none of the controls had plaques and the difference was statistically insignificant (x 2 = 1.36, p = 0.24) ( Table 4 ). Ultrasonographic findings of the common carotid artery are shown in ( A statistically significant increase of cc-IMT was observed in BD patients with ocular lesions (t = 4.41, p < 0.001) and vascular lesions (t = 3.57, p < 0.001), while there was an insignificant increase of cc-IMT in patients with oral ulcers (t = 1.73, p = 0.09), genital ulcers (t = 1.92, p = 0.06) skin lesions (t = 0.41, p = 0.69), arthritis (t = 0.7, p = 0.49) or a positive skin Pathergy test (t = 0.5, P = 0.62) ( Table 5) . On correlating VEGF serum levels with some variables among BD patients, they were found to have statistically significant positive correlations with ESR (r = 0.29, p = 0.14), CRP (r = 0.89, p < 0.001) and BDCAF (r = 0.278, p = 0.02) (Fig. 2) . Correlating cc-IMT with different disease variables, statistically significant correlations were found with age (r = 0.51, p < 0.001), disease duration (r = 0.51, p < 0.001), systolic blood pressure (r = 0.26, p = 0.03), diastolic blood pressure (r = 0.24, p = 0.04), total cholesterol (r = 0.46, p < 0.001) and LDL (r = 0.49, p < 0.001) and an insignificant correlation was found with BDCAF (r = 0.23, p = 0.05) ( Table 6 ). An insignificant correlation was observed between cc-IMT and serum VEGF levels (r = 0.194, p = 0.107) (Fig. 3 ).
Discussion
Behc¸et's disease is a systemic immune-inflammatory vasculitic disease with endothelial dysfunction [20] . All types and sizes of blood vessels can be affected [9] . Systemic vasculitis and endothelial dysfunction are the main features of BD inflammatory process which is maintained by angiogenesis [21] . In this study we aimed to investigate serum levels of VEGF and to measure cc-IMT in Egyptian patients with BD to evaluate their relations to disease activity and different clinical manifestations. This study demonstrated that serum levels of VEGF were significantly increased in BD patients compared to healthy controls (p < 0.001). This was consistent with the results of previous reports [22] [23] [24] [25] . The mechanism of increased serum VEGF levels and its mode of action may be explained as follows: endothelial cells have a special importance among the cells that secrete VEGF [26, 6] . In vasculitis, inflammation stimulates the expression of VEGF which leads to the formation of new capillary networks [27] .
In our study a significant elevation of VEGF serum levels in BD patients with skin lesions (p < 0.001) and with ocular manifestations (p < 0.001) was observed. Shaker et al. [25] revealed elevation of VEGF serum levels in BD patients with ocular manifestations [25] . Kamoun et al. [6] stated that elevated serum levels of VEGF in BD patients with ocular lesions propose a central role for VEGF in ocular events in BD. Moreover, Scaria and his colleagues [28] supported the theory of increased formation of VEGF by retinal cells and its pivotal role in ocular neovascularization. In contrast to our study, Bozoglu et al. [22] found no significant differences of VEGF serum levels in BD patients with skin lesions. Significant elevation of VEGF serum levels with clinical vascular lesions was found in this study (p < 0.001). This confirms the previous studies [22, 25] .
We found significant positive correlations of VEGF serum levels with ESR and CRP while Bozoglu et al. [22] revealed that serum VEGF levels did not correlate with either ESR or CRP. Also there was a significant positive correlation of VEGF serum levels with BDCAF (p = 0.02). Ç ekmen et al. [29] found significantly higher VEGF serum levels in BD patients with active disease and stated that elevated serum levels VEGF can be considered a disease activity marker that may be related to endothelial dysfunction essential in the etiopathogenesis of BD. In addition, Yalc¸in et al. [23] found overexpression of VEGF in their study on BD patients and suggested that this elevation occurs mainly during the active stage of the disease in the case of ocular involvement and in acute thrombosis. On the other hand Erdem et al. [30] demonstrated that the levels of serum VEGF were similar in both active and inactive BD patients. Kamoun et al. [6] supported the role of VEGF in the inflammatory process and angiogenesis and suggested that there is codependence between chronic inflammation and angiogenesis both are a recognized stimulus for production of VEGF and contribute to the pathophysiology of BD.
Common carotid intima media thickness is a widely accepted marker key event of subclinical atherosclerosis [14] . We found a significant increase of cc-IMT in BD patients compared to healthy controls (p = 0.011). These results are consistent with previous reports [31, 9, 32, 14] . Contrary to these results Rhee et al. [33] found insignificant differences in cc-IMT values between BD patients and control subjects and they did not find any carotid plaques in BD patients or control subjects. However, they reported that BD patients have significantly increased arterial stiffness when compared to controls that suggest carotid artery endothelial function impairment. Tyrrell et al. [34] explained the importance of cc-IMT as follows: for an absolute carotid IMT difference of 0.1 mm the future risk of myocardial infarction increases by 10-15% and the stroke risk increases by 13-18%.
This study revealed a significant increase of cc-IMT in BD patients with ocular lesions (p < 0.001) and vascular lesions (p < 0.001) while there was an insignificant increase of cc-IMT in patients with arthritis (p = 0.49). These results are consistent with those of Hong et al. [14] who found cc-IMT increased in BD patients with posterior uveitis or retinal vasculitis and with Alan et al. [31] who revealed a significant increase in cc-IMT in BD patients with vascular involvement. Hassan et al. [35] in their study on Egyptian BD patients found no significant difference when compared to the cc-IMT of these patients with regard to the presence and absence of arthritis along with the involvement of ocular lesions.
The present study revealed a significant correlation between cc-IMT and age, disease duration, systolic BP, diastolic BP, total cholesterol and LDL which are known factors to promote atherogenesis. Our results were in agreement with those of Keser et al. [9] who found that cc-IMT in BD patients correlated with age and disease duration. Hong et al. [14] found cc-IMT to be significantly correlated with age. Also Caliskan et al. [36] observed correlation between cc-IMT and age, disease duration, triglycerides and LDL cholesterol values. In addition Rhee et al. [31] in their study on Korean BD patients noted a positive relationship between age and cc-IMT.
Sherer and Shoenfeld [37] stated that endothelial cell dysfunction occurs early in atherosclerosis and results from oxidation of low density lipoprotein cholesterol. Bacon and his associates [38] reported that endothelial cell dysfunction correlated with CRP and that CRP can predict future coronary events. However we did not find correlations of cc-IMT with CRP or ESR that was in accordance to the results of Keser et al. and Hong et al. [9, 14] .
In the present study there was statistically insignificant correlation between cc-IMT and BDCAF. These results are consistent with those of Hong et al. [14] . However, Hassan et al. [35] revealed a significant correlation between the BDCAF and cc-IMT in BD patients.
We found atheromatous plaques in 4.3% of BD with an insignificant increase of this frequency in comparison to the control group (p = 0.243). This result was in agreement with a previous study [39] . Contrarily, Keser et al. [9] found that the plaque frequency in BD patients was significantly higher than in healthy controls. This incongruity could be explained by differences in some related factors such as gender, BMI, medications, blood pressure and lipids which can potentially affect atherosclerotic plaques formation.
In the present study we found an insignificant correlation between cc-IMT and VEGF serum levels in BD patients (p = 0.107). Ö ztu¨rk et al. [8] found an insignificant correlation between cc-IMT and VEGF levels neither in BD patients nor in healthy controls and suggested that VEGF elevation may be a feature of the inflammatory reaction during the course of BD.
In conclusion, BD patients have ultrasonographic evidence of subclinical atherosclerosis which was associated with increasing age, longer disease duration, elevated systolic and diastolic BP, total cholesterol and LDL. Elevated VEGF showed statistically significant positive correlations with BDCAF and thus can be used as a marker of disease activity and/or therapeutic targets in BD patients.
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